Cognitive behavior therapy boosts outcomes in depressed diabetes patients

11/1/2013 | DailyRx.com

Data on patients with uncontrolled type 2 diabetes and depression revealed that those who underwent cognitive behavioral therapy for adherence and depression attained better A1C levels and exhibited greater adherence to oral medication and self-monitoring of blood glucose at four months compared with those in the Enhanced Treatment as Usual arm. The findings were published in Diabetes Care.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD